Bradykinin receptors as a therapeutic target

Bibliography

• BHOOLA KD, FIGUEROA CD, WORTHY K: Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev (1992) 44:1–80.
   PubMed Web of Science ®Google Scholar
• DUNCAN A-M, KLADIS A, JENNINGS GL, DART AM, ESLER M, CAMPBELL DJ: Kinins in humans. Am. J. Physiol (2000) 278:R897–R904.
   Google Scholar
• ••A scholarly review of the biology andpathology of kinins.
   Google Scholar
• KOZIK A, MOORE RB, POTEMPA J, IMAMURA T, RAPALA-KOZIK M, TRAVIS J: A novel mechanism for bradykinin production at inflammatory sites. J. Biol. Chem. (1998) 273:33224–33299.
   PubMedGoogle Scholar
• •An alternative mechanism for the enzymatic production of kinins.
   Google Scholar
• STEWART JM: Bradykinin antagonists: developments and applications. Biopolymers (1995) 37:143–155.
   PubMed Web of Science ®Google Scholar
• ••A review of kinin receptor biology and thedevelopment of antagonists written by a leading expert.
   Google Scholar
• WARD PE: Metabolism of bradykinin and bradykinin analogues. In: Bradykinin antagonists. Burch RM (Ed.) Marcel Dekker, Inc., New York (1991):147–170.
   Google Scholar
• PROUD D, BAUMGARTEN CR, NACLERIO RM, WARD PE: Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. j Immunol (1987) 128:428–424.
   Google Scholar
• MURPHEY LJ, HACHEY DL, OATES JA, MORROW JD, BROWN NJ: Metabolism of bradykinin in vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite. J. Pharmacol Exp. Ther. (2000) 294:263–269.
   PubMed Web of Science ®Google Scholar
• MENKE JG, BORKOWSKI JA, BIERILO KK et al.: Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. (1994) 269:21583–21586.
   PubMed Web of Science ®Google Scholar
• ••The first sequence of a human 131-receptor.
   Google Scholar
• PHAGOO SB, POOLE S, LEEB-LUNDBERG LMF: Autoregulation of bradykinin receptors: agonists in the presence of interleukin- I beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol (1999) 56:325–333.
   PubMedGoogle Scholar
• NI A, CHAO L, CT-LAO J: Transcription factor nuclear factor 1c13 regulates the inducible expression of the human B1 receptor gene in inflammation. I Biol. Chem. (1998) 273:2784–2791.
   Google Scholar
• FATHY DB, KYLE DJ, LEEB- LUNDBERG LM: High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor. Mol Pharmacol (2000) 57:171–179.
   PubMed Web of Science ®Google Scholar
• LEEB-LUNDBERG LMF, KANG DS, LAMB ME, FATHY DB: The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. _J. Biol. Chem. (2001) 276:8785–8792.
   PubMedGoogle Scholar
• REGOLI D, GOBEIL F, NGUYEN QT etal.: Bradykinin receptor types and B2 subtypes. Life Sci. (1993) 71:55–567.
   Google Scholar
• ••Classification of kinin receptors by aleading expert.
   Google Scholar
• HESS JF, BORKOWSKI JA, YOUNG JS, STRADER CD, RANSOM RW: Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. (1992) 184:260–268.
   PubMed Web of Science ®Google Scholar
• ••Primary sequence of a human B2-receptor.
   Google Scholar
• EGGERICKZ D, RASPE E, BERTRAND D, VASSART G, PARMENTIER M: Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene. Biochem. Biophys. Res. Commun. (1992) 187:260–268.
   Google Scholar
• ••Primary sequence of a human B2-receptor.
   Google Scholar
• HOWL J, YARWOOD NJ, DAVIES ARL, WHEATLEY M: Renal bradykinin and vasopressin receptors: ligand selectivity and classification. Kidney Int. (1996) 50:586–592.
   PubMedGoogle Scholar
• HECQUET C, TAN F, MARCIC BM, ERDOS EG: Human bradykinin B2 receptor is activated by kallikrein and other serine proteases. Mol Pharm. (2000) 58:828–836.
   PubMed Web of Science ®Google Scholar
• •A novel mechanism of kinin receptor activation.
   Google Scholar
• MARIE J, KOCH C, PRUNEAU D et al:Constitutive activation of the human bradykinin B-2 receptor induced by mutations in transmembrane helices III and VI. Md. Pharmacol (1999) 55:92–102.
   Google Scholar
• FATHY DB, LEEB T, MATHIS SA, LEEB-LUNDBERG LMF: Spontaneous human B2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists. I Biol. Chem. (1999) 274:29603–29606.
   Google Scholar
• REGOLI D, JUKIC D, GOBEIL F, RHALEB N-E: Receptors for bradykinin and related kinins: a critical analysis. Can. J. Physiol Pharmacol. (1993) 71:556–567.
   PubMedGoogle Scholar
• SAHA JK, SENGUPTA JN, GOYAL RK: Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter - characterization of an inhibitory bradykinin receptor. J. Pharmacol Exp. The': (1991) 259:265–273.
   PubMed Web of Science ®Google Scholar
• NEUGEBAUER W, BLAIS PA, HALLE S, FILTEAU C, REGOLI D, GOBEIL F: Kinin B-1 receptor antagonists with multi-enzymatic resistance properties. Can. J. Physiol Pharmacol. (2002) 80:287–292.
   PubMedGoogle Scholar
• STEWART JM, GERA L, YORK EJ, CT-LAN DC, BUNN P: Bradykinin antagonists: present progress and future prospects. Immunopharmacology (1999) 43:155–161.
   PubMedGoogle Scholar
• STEWART JM, GERA L, YORK EJ et al: Metabolism-resistant bradykinin antagonists: development and applications. Biol. Chem. (2001) 382:37–41.
   PubMed Web of Science ®Google Scholar
• RIZZI C, RIZZI A, CALO G etal.: Characterization of FR 172357, a new non-peptide bradykinin B(2) receptor antagonist, in human, pig and rabbit preparations. Eur Pharmacol (1999) 386:25–31.
   Google Scholar
• •Development of a non-peptide B2-selective antagonist with therapeutic potential.
   Google Scholar
• ARAMORI I, ZENKOH J, MORIKAWA N et al.: Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor. Mol Pharmacol (1997) 52:16–20.
   PubMed Web of Science ®Google Scholar
• RIZZI A, RIZZI C, AMADESI S et al: Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors. Naurgh-Schmeidebergi Arch. Pharmacol (1999) 360:361–367.
   PubMedGoogle Scholar
• •A novel non-peptide agonist for B2 receptors.
   Google Scholar
• CHAVAKIS T, KANSE SM, PIXLEY RA et al.: Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB (2001) 15:2365–2376.
   PubMedGoogle Scholar
• AHLUWALIA A, PERRETTI M: B1 receptors as a new inflammatory target. Could this B the 1. Trends Pharmacol Sci (1999) 20:100–104.
   PubMedGoogle Scholar
• •An excellent review of data supporting a pro-inflammatory role of the B1-receptor.
   Google Scholar
• COUTURE R, HARRISSON M, VIANNA RIVI, CLOUTIER F: Kinin receptors in pain and inflammation. Eur. Pharmacol. (2001) 429:161–176.
   PubMed Web of Science ®Google Scholar
• SCHREMMER-DANNINGER E, OFFNER A, SIEBECK M, ROSCHER AA: B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem. Biophys. Res. Commun. (1998) 243:246–252.
   PubMed Web of Science ®Google Scholar
• DRAY A: Kinins and their receptors in hyperalgesia. Can. j Physiol. Pharmacol. (1997) 75:704–712.
   PubMed Web of Science ®Google Scholar
• STEWART JM: Bradykinin B2 receptor antagonists: development and applications. Can. j Physiol. Pharmacol (1995) 73:787–790.
   PubMedGoogle Scholar
• ASANO M, HATORI C, INAMURA N et al.: Effects of a non-peptide bradykinin B2 receptor antagonist, FR 167344, on different in vivo animal models of inflammation. Br .j Pharmacol. (1997) 122:1436–1440.
   PubMedGoogle Scholar
• MARCEAU F, HESS JF, BACHVAROV DR: The B1 receptors for kinins. Pharmacol. Rev (1998) 50:357–386.
   PubMed Web of Science ®Google Scholar
• •An exhaustive review of B1-receptor biology and pathology.
   Google Scholar
• PESQUERO JB, ARAUJO RC, HEPPENSTALL PA et al.: Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Nati Acad. Sci. USA (2000) 97:8140–8145.
   PubMed Web of Science ®Google Scholar
• CRUWYS SC, GARRETT NE, PERKINS MN, BLAKE DR, KIDD BL: The role of bradykinin B-1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. j Pharmacol. (1994) 113:940–944.
   PubMedGoogle Scholar
• DE WITT BJ, CHENG DY, KADOWITZ PJ: Des-Arg9-bradykinin produces tone-dependent kinin B1 receptor-mediated responses in the pulmonary vascular bed. Circ. Res. (1994) 75:1064–1072.
   PubMedGoogle Scholar
• BELICHARD P, LOILLIER B, PAQUET JL, LUCCARINI JM, PRUNEAU D: Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs. Br .j Pharmacol. (1996) 117:1565–1571.
   PubMedGoogle Scholar
• WOHLFART E DEDIO J, WIRTH K, SCHOLKENS BA, WIEMER G: Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species. j Pharmacol. Exp. Ther. (1997) 280:1109–1116.
   PubMedGoogle Scholar
• PRAT A, BIERNACKI K, POULY S, NALBATOGLU J, COUTURE R, ANTEL JP: Kinin B-1 receptor expression and function on human brain endothelial cells. j Neuropathol. Esp. Neural. (2000) 59:896–906.
   PubMedGoogle Scholar
• SARDI SP, ARES VR, ERRASTI AE, ROTHLIN RP: Bradykinin B1 receptors in human umbilical vein: pharmacological evidence of up-regulation, and induction by interleukin-113. Eur. j Pharmacol. (1998) 358:221–227.
   PubMedGoogle Scholar
• SARDI SP, DARAY FM, ERRASTI AE et al.: Further pharmacological characterization of bradykinin B1 receptor up-regulation in human umbilical vein. Pharmacol. Esp. Ther. (1999) 290:1019–1025.
   PubMedGoogle Scholar
• MCLEAN PG, PERRETTI M, AHLUWALIA A: Kinin Bl-receptors and the cardiovascular system: regulation of expression and function. Cardiovasc. Res. (2000) 48:194–210.
   PubMed Web of Science ®Google Scholar
• •An excellent review of B1-receptors and their role in the cardiovascular system.
   Google Scholar
• ALFIE ME, YANG XP, HESS F, CARRETERO OA: Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem. Biophys. Res. Commun. (1996) 224:625–630.
   PubMed Web of Science ®Google Scholar
• DUNCAN AM, BURRELL LM, KLADIS A, CAMPBELL DJ: Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. Cardiovasc. Pharmacol. (1996) 28:746–754.
   PubMed Web of Science ®Google Scholar
• SHIGEMATSU S, ISHIDA S, GUTE DC, KORTHUIS RJ: Bradykinin prevents postischemic leukocyte adhesion and emigration and attenuates microvascular barrier disruption. Am. j Physiol. (1999) 277:H161–H171.
   Google Scholar
• VEGH A, SZEKERES L, PARRATT JR: Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br. J Pharmacol. (1991) 104:294–295
   PubMed Web of Science ®Google Scholar
• BAUMGARTEN CR, LINZ W, KUNKEL G, SCHOLKENS BA, WIEMER G: Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br j Pharmacol. (1993) 108:293–295.
   PubMed Web of Science ®Google Scholar
• GROVES E KURZ S, JUST H, DREXLER H: Role of endogenous bradykinin in human coronary vasomotor control. Circulation (1995) 92:3424–3230
   PubMedGoogle Scholar
• KUGA T, EGASHIRA K, MOHRI M et al.:Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation (1995) 92:183–189.
   PubMedGoogle Scholar
• EMANUELI C, SALIS MB, STACCA T et al.: Targeting kinin B-1 receptor for therapeutic neovascularization. Circulation (2002) 105:360–366.
   PubMed Web of Science ®Google Scholar
• SQUIRE IB, UKANE KP, ANDERSON N, REID JL: Bradykinin B (2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension (2000) 36:132–136.
   PubMed Web of Science ®Google Scholar
• WITHEROW FN, HELMY A, WEBB DJ, FOX KA, NEWBY DE: Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation (2001) 104:2177–2181.
   PubMed Web of Science ®Google Scholar
• DOCTROW SR, ABELLEIRA SM, CURRY LA et al.: The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. j Pharmacol. Exp. The': (1994) 271:229–237.
   Google Scholar
• BARTUS RT, SNOD GRASS E MARSH J, AGOSTINO M, PERKINS A, EMERICH DF: Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival. ..J. Pharmacol. Esp. Ther. (2000) 293:903–911.
   PubMed Web of Science ®Google Scholar
• EMERICH DF, DEAN RL, OSBORN C, BARTUS RT: The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation. Pharmacokiriet. (2001) 40:105–123.
   PubMed Web of Science ®Google Scholar
• ••Therapeutic application of a BK agonist.
   Google Scholar
• SANOVICH E, BARTUS RT, FRIDEN PM, DEAN RL, LE HQ, BRIGHTMAN MW: Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res. (1995) 705:125–135.
   PubMed Web of Science ®Google Scholar
• WARREN KE, PATEL MC, AIKIN AA et al.: Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors. Cancer Chemother. Pharmacol. (2001) 48:275–282
   PubMed Web of Science ®Google Scholar
• •Additional evidence that cereport is a promising therapeutic.
   Google Scholar
• THOMAS HD, LIND MJ, FORD J, BLEEHAN N, CALVERT AH, BODDY AV: Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RIVIP-7) for the treatment of brain tumours. Cancer Chemother. Pharmacol. (2000) 45:284–290.
   PubMedGoogle Scholar
• •A novel therapeutic application of a B2-receptor agonist.
   Google Scholar
• MAJIMA M, KATORI M: Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. Trends Pharmacol Sci. (1995) 16:239–246.
   PubMedGoogle Scholar
• SCHANSTRA JP, ALRIC C, MARIN-CASTANO ME, GIROLAMI J-P, BASCANDS J-L: Renal bradykinin receptors: localisation, transduction pathways and molecular basis for a possible pathological role (review). Int. J. Ma] Med. (1999) 3:185–191.
   PubMedGoogle Scholar
• MARGOLIUS HS: Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension (1995) 26:221–229.
   Google Scholar
• DAFFIX I, AMBLARD M, BERGE G: Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140. j Pept. Res. (1998) 52:1–14.
   PubMedGoogle Scholar
• CHERONIS JC, WHALLEY ET, ALLEN LG et al: Design, synthesis and in vitro activity of bis (succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activity. J. Med. Chem. (1994) 37:348–355.
   PubMedGoogle Scholar
• HOWL J, LANGEL U, HAWTIN SR et al: Chimeric strategies for the rational design of bioactive analogs of small peptide hormones. FASEB J. (1997) 11:582–590.
   PubMedGoogle Scholar
• CHAN D, GERA L, STEWART J et al: Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a 'biased agonise mechanism. Proc. Natl. Acad. Li. USA (2002) 99:4608–4613.
   PubMed Web of Science ®Google Scholar
• ••The development of a new class ofanticancer agents.
   Google Scholar
• CHAN D, GERA L, STEWART J et al: Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Chu. Cancer Res. (2002) 8:1280–1287.
   PubMedGoogle Scholar
• STEWART JM, GERA L, CHAN DC et al: Bradykinin-related compounds as new drugs for cancer and inflammation. Can. J. Physiol. Pharmacol (2002) 80:275–280.
   PubMedGoogle Scholar
• ••A timely review of novel kinin analogues asanticancer agents.
   Google Scholar
• WIRTH KJ, HEITSCH H, SCHOLKENS BA: Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharmacol (1995) 73:797–804.
   PubMed Web of Science ®Google Scholar
• BHOOLA R, RAMSAROOP R, NAIDOO S, MOLLER-ESTER L, BHOOLA KD: Kinin receptor status in normal and inflamed gastric mucosa. Immunopharmacology (1997) 36:161–165.
   PubMedGoogle Scholar
• ROISMAN GL, LACRONIQUE JG, DESMAZES-DUFEU N, CARRE C, LE CAE A, DUSSER DJ: Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am. J. Respir. Crit. Care Med. (1996) 153:381–390.
   PubMedGoogle Scholar
• BARNES PJ, CHUNG KF, PAGE CP: Inflammatory mediators of asthma: an update. Pharmacol Rev (1998) 50:515–596.
   PubMed Web of Science ®Google Scholar
• RICCIARDOLO FLM, GEPPETTI P, MISTRETTA A et al.: Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet (1996) 348:374–377.
   PubMedGoogle Scholar
• DOUILLET CD, VELARDE V, CHRISTOPHER JT, MAYFIELD RK, TROJANOWSKA ME, JAFFA AA: Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-I3 and MAPK. Am. J. Physic] (2000) 279:H2829–H2837.
   Google Scholar
• FINK MP: Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. J. Antomicrob. Chemother (1998) 41 (Suppl. A):81–94.
   Google Scholar
• PRAT A, WEINRIB L, BECHER B et al: Bradykinin B-1 receptor and expression and function on T lymphocytes in active multiple sclerosis. Neurology (1999) 53:2087–2092.
   PubMed Web of Science ®Google Scholar
• POLOSA R, DJUKANOVIC R, RAJAKULASINGAM K, PALERMO F, HOLGATE ST: Skin responses to bradykinin kallidin and klesArg91-bradykinin in nonatopic and atopic volunteers. J. Allergy Chu. Immunol. (1993) 92:683–689.
   PubMedGoogle Scholar
• SCHREY MP, HOLT JR, CORNFORD PA, MONAGHAN H, AL-UBAIDI F: Human decidua is a target tissue for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro. J. Chu. Endocrinol. Metab. (1992) 74:426–435.
   PubMedGoogle Scholar
• MAD DEDU P, PARPAGLIA PP, GLORIOSO N, CHAO L, CHAO J: Antisense inhibition of the brain kallikrein-kinin system. Hypertension (1996) 28:980–987.
   PubMedGoogle Scholar
• RAIDOO DM, BHOOLA KD: Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue. Pharmacol The': (1998) 79:105–127.
   Google Scholar
• •A scholarly review of the roles of kinins in the mammalian nervous system.
   Google Scholar
• CHERONIS JC, WHALLEY ET, NYGUYEN KT et al: A new class of bradykinin antagonists: synthesis and in vitro activity of bis-succinimidoalkane peptide dimers. J. Med. Chem. (1992) 35:1563–1572.
   PubMed Web of Science ®Google Scholar